Cargando…
Apoe4 and Alzheimer’s Disease Pathogenesis—Mitochondrial Deregulation and Targeted Therapeutic Strategies
APOE ε4 allele (ApoE4) is the primary genetic risk factor for sporadic Alzheimer’s disease (AD), expressed in 40–65% of all AD patients. ApoE4 has been associated to many pathological processes possibly linked to cognitive impairment, such as amyloid-β (Aβ) and tau pathologies. However, the exact me...
Autores principales: | Pires, Mariana, Rego, Ana Cristina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9821307/ https://www.ncbi.nlm.nih.gov/pubmed/36614219 http://dx.doi.org/10.3390/ijms24010778 |
Ejemplares similares
-
Roles of ApoE4 on the Pathogenesis in Alzheimer’s Disease and the Potential Therapeutic Approaches
por: Sun, Yu-Ying, et al.
Publicado: (2023) -
ApoE in Alzheimer’s disease: pathophysiology and therapeutic strategies
por: Raulin, Ana-Caroline, et al.
Publicado: (2022) -
ApoE4: an emerging therapeutic target for Alzheimer’s disease
por: Safieh, Mirna, et al.
Publicado: (2019) -
The role of APOE4 in Alzheimer’s disease: strategies for future therapeutic interventions
por: Hunsberger, Holly C., et al.
Publicado: (2019) -
Boldine Attenuates Synaptic Failure and Mitochondrial Deregulation in Cellular Models of Alzheimer’s Disease
por: Toledo, Juan P., et al.
Publicado: (2021)